Parents whose children have been diagnosed with attention deficit hyperactivity disorder (ADHD) may be overwhelmed by the wealth of information accessible to them. The good news for parents whose child has been diagnosed with ADHD is that it is treatable.
Current ADHD medicines are being tested in clinical studies to determine how well they work in helping adolescents control their condition and their behavior. If your child has been diagnosed with ADHD and you want to make sure they have access to the most cutting-edge treatment and specialists, you should look into ADHD clinical trials in Miami.
In one such study, Otsuka is researching a novel drug named Centanafadine. This Study Drug has completed late-stage clinical testing and is currently being submitted to the FDA for adult approval. The purpose of this study is to broaden the range of treatment options available to those dealing with ADHD.
In this study, your child will be randomly assigned to either Centanafadine or a placebo for the first six weeks, followed by the active medication for the remaining 52 weeks. Placebos are inactive substances that look like the Study Drug but do not contain any of the active drug being studied. A placebo will be used by researchers to test whether or not the Study Drug has an impact. To apply for or learn more about this study, please go here.
At Miami Clinical Research, we are a group of healthcare professionals dedicated to improving the quality of health and wellness through medical research. If you’re ready to start looking for a clinical trials in Miami, visit us online to explore studies and see if one fits your needs.
